Liver Biopsy in Modern Clinical Practice

Rockey, 2009, Liver biopsy., Hepatology, 49, 1017, 10.1002/hep.22742

Czaja, 2007, Optimizing diagnosis from the medical liver biopsy., Clin Gastroenterol Hepatol, 5, 898, 10.1016/j.cgh.2007.05.031

Altman, 1997, A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers., Ann Surg, 226, 348, 10.1097/00000658-199709000-00014

Ibrahim, 1997, Japanese Biliary Atresia Registry, 1989 to 1994., Tohoku J Exp Med, 181, 85, 10.1620/tjem.181.85

Karrer, 1990, Biliary atresia registry, 1976 to 1989., J Pediatr Surg, 25, 1076, 10.1016/0022-3468(90)90222-U

McKiernan, 2002, Neonatal cholestasis., Semin Neonatol, 7, 153, 10.1053/siny.2002.0103

Moyer, 2004, Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American society for pediatric gastroenterology, hepatology and nutrition., J Pediatr Gastroenterol Nutr, 39, 115, 10.1097/00005176-200408000-00001

Hay, 1989, The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients., Hepatology, 9, 193, 10.1002/hep.1840090205

Skelly, 2001, Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology., J Hepatol, 35, 195, 10.1016/S0168-8278(01)00094-0

Sorbi, 2000, An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities., Am J Gastroenterol, 95, 3206, 10.1111/j.1572-0241.2000.03293.x

Johnson, 1993, Meeting report: International Autoimmune Hepatitis Group., Hepatology, 18, 998, 10.1002/hep.1840180435

Alvarez, 1999, Report: review of criteria for diagnosis of autoimmune hepatitis., J Hepatol, 31, 929, 10.1016/S0168-8278(99)80297-9

Gassert, 2007, Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis., Dig Dis Sci, 52, 2433, 10.1007/s10620-006-9665-4

Dave, 2010, Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography., Radiology, 256, 387, 10.1148/radiol.10091953

Harrison, 1991, The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis., Histopathology, 19, 321, 10.1111/j.1365-2559.1991.tb00046.x

Gregorio, 2001, Autoimmune hepatitissclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study., Hepatology, 33, 544, 10.1053/jhep.2001.22131

Fairbanks, 2008, Liver disease in alpha 1-antitrypsin deficiency: a review., Am J Gastroenterol, 103, 2136, 10.1111/j.1572-0241.2008.01955.x

Talbot, 1975, Liver disease in infancy. Histological features and relationship to alpha 1-antitrypsin phenotype., J Clin Pathol, 28, 559, 10.1136/jcp.28.7.559

Rowe, 2005, Mechanisms of disease, cystic fibrosis., N Engl J Med, 352, 1992, 10.1056/NEJMra043184

Colombo, 2002, Liver disease in cystic fibrosis: a prospective study on incidence, risk factors and outcome., Hepatology, 36, 1374, 10.1002/hep.1840360613

Wilschanski, 1999, Clinical and genetic risk factors for CF-related liver disease., Pediatrics, 103, 52, 10.1542/peds.103.1.52

Bartlett, 2009, Genetic modifiers of liver disease in cystic fibrosis., JAMA, 302, 1076, 10.1001/jama.2009.1295

Sokol, 1999, Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group., J Pediatr Gastroenterol Nutr, 28, 1, 10.1097/00005176-199900001-00001

Strandvik, 1988, Sclerosing cholangitis in cystic fibrosis., Scand J Gastroenterol Suppl, 143, 121, 10.3109/00365528809090231

Morotti, 2011, Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings., Semin Liver Dis, 31, 3, 10.1055/s-0031-1272831

Alissa, 2008, Update on progressive familial intrahepatic cholestasis., J Pediatr Gastroenterol Nutr, 46, 241, 10.1097/MPG.0b013e3181596060

Clayton, 1969, Byler Disease. Fatal familial intrahepatic cholestasis in an Amish kindred., Am J Dis Child, 117, 112, 10.1001/archpedi.1969.02100030114014

Linarelli, 1972, Bylers disease: fatal intrahepatic cholestasis., J Pediatr, 81, 484, 10.1016/S0022-3476(72)80174-4

Jansen, 1999, Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis., Gastroenterology, 117, 1370, 10.1016/S0016-5085(99)70287-8

Strautnieks, 2008, Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families., Gastroenterology, 134, 1203, 10.1053/j.gastro.2008.01.038

Knisely, 2006, Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency., Hepatology, 44, 478, 10.1002/hep.21287

Jacquemin, 2001, The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood., Gastroenterology, 120, 1448, 10.1053/gast.2001.23984

Jacquemin, 2001, Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases., Semin Liver Dis, 21, 551, 10.1055/s-2001-19033

Clayton, 2011, Disorders of bile acid synthesis., J Inherit Metab Dis, 34, 593, 10.1007/s10545-010-9259-3

Roberts, 2008, Diagnosis and treatment of Wilson disease: an update. American Association for Study of Liver Diseases (AASLD)., Hepatology, 47, 2089, 10.1002/hep.22261

Martins da Costa, 1992, Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilsons disease., Hepatology, 15, 609, 10.1002/hep.1840150410

Song, 2000, A single determination of liver copper concentration may misdiagnose Wilsons disease., Clin Biochem, 33, 589, 10.1016/S0009-9120(00)00164-8

Ozen, 2007, Glycogen storage diseases: new perspectives., World J Gastroenterol, 13, 2541, 10.3748/wjg.v13.i18.2541

Wolsdorf, 1999, Glycogen storage disease: phenotypic, genetic, and biochemical characteristics, and therapy., Endocrinol Metab Clin, 28, 802

Roy, 2010, Biopsy diagnosis of inherited liver disease., Surg Pathol Clin, 3, 743, 10.1016/j.path.2010.06.006

Hicks, 2011, Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment., Ultrastruct Pathol, 35, 183, 10.3109/01913123.2011.601404

Panetta, 2005, The importance of liver biopsy in the investigation of possible mitochondrial respiratory chain disease., Neuropediatrics, 36, 256, 10.1055/s-2005-865866

Knisely, 1992, Neonatal hemochromatosis., Adv Pediatr, 39, 383, 10.1016/S0065-3101(24)00290-1

Goldfischer, 1981, Idiopathic neonatal iron storage involving the liver, pancreas, heart, and endocrine and exocrine glands., Hepatology, 1, 58, 10.1002/hep.1840010110

Whitington, 2007, Neonatal hemochromatosis: a congenital alloimmune hepatitis., Semin Liver Dis, 27, 243, 10.1055/s-2007-985069

Knisely, 2003, Neonatal hemochromatosis., Gastroenterol Clin North Am, 32, 877, 10.1016/S0889-8553(03)00050-5

Silver, 1993, Hepatic morphology and iron quantitation in perinatal hemochromatosis: comparison with a large perinatal control population, including cases with chronic liver disease., Am J Pathol, 143, 1312

Udell, 2005, Neonatal hemochromatosis: radiographical and histological signs., Liver Transplant, 11, 998, 10.1002/lt.20461

Smith, 2004, Minor salivary gland biopsy in neonatal hemochromatosis., Arch Otolaryngol Head Neck Surg, 130, 760, 10.1001/archotol.130.6.760

Knisely, 1988, Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis., J Pediatr, 113, 871, 10.1016/S0022-3476(88)80022-2

Schwimmer, 2005, Histopathology of pediatric nonalcoholic fatty liver disease., Hepatology, 42, 641, 10.1002/hep.20842

Brunt, 2010, Pathology of nonalcoholic fatty liver disease., Nat Rev Gastroenterol Hepatol, 7, 195, 10.1038/nrgastro.2010.21

Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease., Hepatology, 41, 1313, 10.1002/hep.20701

Carter-Kent, 2009, Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study., Hepatology, 50, 1113, 10.1002/hep.23133

Polson, 2005, American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure., Hepatology, 41, 1179, 10.1002/hep.20703

Miraglia, 2006, Contribution of transjugular liver biopsy in patients with the clinical presentation of acute liver failure., Cardiovasc Intervent Radiol, 29, 1008, 10.1007/s00270-006-0052-5

Bakshi, 2006, Fine needle aspiration biopsy in pediatric space-occupying lesions of liver: a retrospective study evaluating its role and diagnostic efficacy., J Pediatr Surg, 41, 1903, 10.1016/j.jpedsurg.2006.06.027

Weinberg, 1983, Primary hepatic tumors of childhood., Hum Pathol, 14, 512, 10.1016/S0046-8177(83)80005-7

Litten, 2008, Liver tumors in children., Oncologist, 13, 812, 10.1634/theoncologist.2008-0011

Haas, 2001, Small cell undifferentiated histology in hepatoblastoma may be unfavorable., Cancer, 92, 3130, 10.1002/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#

Rosenthal, 2008, Hepatocarcinoma in viral and metabolic liver disease., J Pediatr Gastroenterol Nutr, 46, 370, 10.1097/MPG.0b013e318158799b

Czauderna, 2002, Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group., J Clin Oncol, 20, 2798, 10.1200/JCO.2002.06.102

Hadzic, 2011, Hepatocellular carcinoma in biliary atresia: Kings College Hospital experience., J Pediatr, 159, 617, 10.1016/j.jpeds.2011.03.004

Bianchi, 1993, Glycogen storage disease I and hepatocellular tumors., Eur J Pediatr, 152, 563, 10.1007/BF02072092

Van Spronson, 2005, Hepatocellular carcinoma in hereditary tyrosinemia type 1 despite 2 (-2 nitro 4-3 trifluoro-methyl-benzenyl) 1-3 cyclohexanedione therapy., J Pediatr Gastroenterol Nutr, 40, 90, 10.1097/00005176-200501000-00017

Hadzic, 2006, Hepatocellular carcinoma in a 12 y old child with PiZZ alpha-I-antitrypsin deficiency., Hepatology, 43, 514, 10.1002/hep.21009

Halvorsen, 1995, Co-existing hepatocellular carcinoma in a patient with arteriohepatic dysplasia., Abdom Imaging, 20, 191, 10.1007/BF00200391

Ward, 2011, Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors., Semin Liver Dis, 31, 61, 10.1055/s-0031-1272835

Bruix, 2011, Management of hepatocellular carcinoma: an update., Hepatology, 53, 1020, 10.1002/hep.24199

Huang, 1996, Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinomaa study based on 420 patients., J Hepatol, 25, 334, 10.1016/S0168-8278(96)80120-6

Durand, 2001, Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma., J Hepatol, 35, 254, 10.1016/S0168-8278(01)00108-8

Blasco, 2006, Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation., Hepatology, 43, 492, 10.1002/hep.21090

Firpi, 2004, One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection., Liver Transplant, 10, 1240, 10.1002/lt.20238

Abraham, 2008, Significance of central perivenulitis in pediatric liver transplantation., Am J Surg Pathol, 32, 1479, 10.1097/PAS.0b013e31817a8e96

Sundaram, 2006, Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients., Liver Transplant, 12, 58, 10.1002/lt.20661

Gouw, 2002, The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection., Transplantation, 73, 243, 10.1097/00007890-200201270-00016

Jonas, 2010, Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options., Hepatology, 52, 2192, 10.1002/hep.23934

Jara, 1999, Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children., J Pediatr Gastroenterol Nutr, 29, 163, 10.1097/00005176-199908000-00012

Woynarowski, 2006, Inter-observer variability in histopathological assessment of liver biopsies taken in a pediatric open label therapeutic program for chronic HBV infection treatment., World J Gastroenterol, 12, 1713, 10.3748/wjg.v12.i11.1713

Sokal, 1998, Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial., Gastroenterology, 114, 988, 10.1016/S0016-5085(98)70318-X

Hom, 2004, Predictors of virologic response to lamivudine treatment in children with chronic hepatitis B., Pediatr Infect Dis J, 23, 441, 10.1097/01.inf.0000126412.93562.f5

Tulikoura, 1982, Huikuri morphological fatty changes and function of the liver, serum free fatty acids and triglycerides during parenteral nutrition., Scand J Gastroenterol, 17, 177, 10.3109/00365528209182037

Beath, 1997, Clinical features and prognosis of children assessed for isolated small bowel (ISBTx) or combined small bowel and liver transplantation., J Pediatr Surg, 32, 459, 10.1016/S0022-3468(97)90606-0

Crawford, 1998, The normal adult human liver biopsy: a quantitative reference standard., Hepatology, 28, 323, 10.1002/hep.510280206

Bedossa, 2003, Sampling variability of liver fibrosis in chronic hepatitis C., Hepatology, 38, 1449, 10.1053/jhep.2003.09022

Hahm, 2001, The value of second opinion in gastrointestinal and liver pathology., Arch Pathol Lab Med, 125, 736, 10.5858/2001-125-0736-TVOSOI

Brough, 1974, Conjugated hyperbilirubinemia in early infancy: a reassessment of liver biopsy., Hum Pathol, 5, 507, 10.1016/S0046-8177(74)80003-1

Bedossa, 1988, Observer variation in assessment of liver biopsies of alcoholic patients., Alcohol Clin Exp Res, 12, 173, 10.1111/j.1530-0277.1988.tb00155.x

Younossi, 1999, Agreement in pathologic interpretation of liver biopsy specimens in posttransplant Hepatitis C infection., Arch Pathol Lab Med, 123, 143, 10.5858/1999-123-0143-AIPIOL

Smith, 1995, The effect of ultrasonography on the performance of routine liver biopsy., Hepatology, 22, 384A, 10.1016/0270-9139(95)95259-4

Lindor, 1996, The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy., Hepatology, 23, 1079, 10.1002/hep.510230522

Stowe, 1996, An audit of ultrasound guided liver biopsies: a need for evidence-based practice., Hepatogastroenterology, 23, 1079

McAfee, 1992, Transjugular liver biopsy., Hepatology, 15, 726, 10.1002/hep.1840150429

Lebrec, 1992, Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure., Gastroenterology, 83, 338, 10.1016/S0016-5085(82)80325-9

Tobin, 1989, Plugged liver biopsy in patients with impaired coagulation., Dig Dis Sci, 34, 13, 10.1007/BF01536147

Riley, 1984, Percutaneous liver biopsy with plugging of needle track: a safe method for use in patients with impaired coagulation., Lancet, 2, 436, 10.1016/S0140-6736(84)92910-6

Sawyer, 1993, A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation., J Hepatol, 17, 81, 10.1016/S0168-8278(05)80525-2

McGill, 1990, A 21-year experience with major hemorrhage after percutaneous liver biopsy., Gastroenterology, 99, 1396, 10.1016/0016-5085(90)91167-5

Piccinino, 1986, Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies., J Hepatol, 2, 165, 10.1016/S0168-8278(86)80075-7

Liu, 2007, Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis., Gastroenterology, 132, 119, 10.1053/j.gastro.2006.10.034

Hirschfield, 2009, Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants., N Engl J Med, 360, 2544, 10.1056/NEJMoa0810440

Huang, 2007, A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C., Hepatology, 46, 297, 10.1002/hep.21695

Chalasani, 2010, Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease., Gastroenterology, 139, 1567, 10.1053/j.gastro.2010.07.057

Nguyen, 2011, Noninvasive assessment of liver fibrosis., Hepatology, 53, 2107, 10.1002/hep.24401

Nobili, 2008, Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis., Hepatology, 48, 442, 10.1002/hep.22376

De Ledinghen, 2007, Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy., J Pediatr Gastroenterol Nutr, 45, 443, 10.1097/MPG.0b013e31812e56ff

Rustogi, 2012, Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis., J Magn Reson Imaging, 35, 1356, 10.1002/jmri.23585

Nobili, 2010, Paediatric nonalcoholic fatty liver disease., Gut, 59, 561, 10.1136/gut.2009.187039

Pacifico, 2007, MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease., Acta Paediatr, 96, 542, 10.1111/j.1651-2227.2007.00186.x

Schwimmer, 2009, Heritability of nonalcoholic fatty liver disease., Gastroenterology, 50, 1072

Imbert-Bismut, 2004, Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors., Clin Chem Lab Med, 42, 323, 10.1515/CCLM.2004.058

Friedrich-Rust, 2010, Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis., BMC Gastroenterol, 10, 103, 10.1186/1471-230X-10-103

Halfon, 2006, Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study., Am J Gastroenterol, 101, 547, 10.1111/j.1572-0241.2006.00411.x

Guha, 2008, Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers., Hepatology, 47, 455, 10.1002/hep.21984

Nobili, 2009, Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease., Gastroenterology, 136, 160, 10.1053/j.gastro.2008.09.013

Feldstein, 2009, Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study., Hepatology, 50, 1072, 10.1002/hep.23050

Seidel, 2005, The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum., Hepatology, 42, 113, 10.1002/hep.20747

Valva, 2010, Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis., J Med Virol, 82, 949, 10.1002/jmv.21699

Joka, 2012, Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis., Hepatology, 55, 455, 10.1002/hep.24734

Adams, 2011, Biomarkers of liver fibrosis., J Gastroenterol Hepatol, 26, 802, 10.1111/j.1440-1746.2010.06612.x

Bell, 2010, Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease., Hepatology, 51, 111, 10.1002/hep.23271

Morra, 2007, Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C., Aliment Pharmacol Ther, 26, 847, 10.1111/j.1365-2036.2007.03427.x

Poon, 2005, Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study., Clin Chem, 51, 328, 10.1373/clinchem.2004.041764